04 December 2019 |

Anaconda Biomed secures €20 Million round of funding

BARCELONA, Spain – Anaconda Biomed S,L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, has closed €20 million in new funding. The funding will be used for clinical studies of the company’s groundbreaking technology, regulatory submissions in international markets, further product development and manufacturing scale-up. “With this new round of funding, we will be